JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 46 filers reported holding JANUX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,444,704 | -0.7% | 3,317,927 | +17.0% | 0.71% | +16.4% |
| Q2 2023 | $33,667,902 | -1.9% | 2,836,386 | 0.0% | 0.61% | -9.5% |
| Q1 2023 | $34,320,271 | -8.1% | 2,836,386 | 0.0% | 0.67% | -5.7% |
| Q4 2022 | $37,355,204 | -2.7% | 2,836,386 | 0.0% | 0.72% | +0.3% |
| Q3 2022 | $38,405,000 | +10.9% | 2,836,386 | 0.0% | 0.71% | +13.5% |
| Q2 2022 | $34,632,000 | -14.9% | 2,836,386 | 0.0% | 0.63% | -4.8% |
| Q1 2022 | $40,674,000 | -27.3% | 2,836,386 | 0.0% | 0.66% | -8.2% |
| Q4 2021 | $55,962,000 | -25.4% | 2,836,386 | -18.2% | 0.72% | -12.7% |
| Q3 2021 | $74,978,000 | -13.3% | 3,466,386 | 0.0% | 0.82% | -5.8% |
| Q2 2021 | $86,486,000 | – | 3,466,386 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $117,401,000 | 2.50% |
| 5AM Venture Management, LLC | 446,266 | $6,042,000 | 1.16% |
| Samsara BioCapital, LLC | 360,414 | $4,880,000 | 1.14% |
| BVF INC/IL | 1,470,334 | $19,908,000 | 0.82% |
| Orbimed Advisors | 2,836,386 | $38,405,000 | 0.71% |
| EcoR1 Capital, LLC | 1,421,319 | $19,245,000 | 0.57% |
| Woodline Partners LP | 400,181 | $5,418,000 | 0.08% |
| Parkwood LLC | 33,352 | $452,000 | 0.07% |
| JANUS HENDERSON GROUP PLC | 3,920,088 | $26,572,546 | 0.02% |
| Cerity Partners LLC | 105,933 | $1,434,000 | 0.02% |